Post by
DamnYankees on Feb 04, 2016 9:26am
Plan X
I have to think that management wasn't surprised by their CRL. Except for a short pre adcom pop, when people that matter jumped ship after a seeking alpha article was published, the share price has been hinting at it since the priority review was announced. Certainly they must have known, with a high probability, since the Adcomm failure. The market knew. It barely traded heading into an FDA decision?.If that is the case why would would they be scrambling for a contingency plan. Wouldn't they already have one in place? Aren't good managers expected to be prepared for the likelihood of the worst, when the signs were everywhere? Why the delay to speak to shareholders?
Comment by
DamnYankees on Feb 04, 2016 1:56pm
John Ford's conservative estimate of a completed P3 is 150 mil US. That is 50 cents/share. The present value of this asset is slightly less than $0.00/share. After the Telesta discount factor is applied I am expecting to be told that 5 to 6 cents is good value for common shareholders. I wish that was stated in jest.
Comment by
vega509 on Feb 04, 2016 3:39pm
DB ...... or maybe they will chose a company to merge with using the same acumen they have showed to date. it is difficult to keep the faith ........
Comment by
DamnYankees on Feb 04, 2016 3:55pm
You are not the only one balancing out the fist full of failures with the empty palm of promise. The dust has nearly settled and the entire MCNA platform is valued at below nothing. Im not sure anyone wants to march on with this leadership, or has any faith that they can fairly value and sell the assets in front of them, let alone acquire new ones.